Financials data is unavailable for this security.
Cash flow in EURView more
In 2023, cash reserves at Biotalys NV fell by 12.53m. Cash Flow from Financing totalled 5.53m or -- of revenues. In addition the company used 18.28m for operations while cash from investing totalled 233.00k.
Cash flow per share | -0.4524 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6099 |
---|---|
Tangible book value per share | 0.5911 |
More ▼
Balance sheet in EURView more
Current ratio | 3.88 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2802 |
---|---|
Total debt/total capital | 0.2189 |
More ▼